ICM
GROW icon

Invenomic Capital Management’s US Global Investors GROW Stock Holding History

Invenomic Capital Management’s Portfolio GROW Stock Details GROW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-158,898
Closed -$154K – 164
2020
Q1 		$154K Sell
158,898
-101,873
-39% -$124K 0.13% 127
2019
Q4 		$376K Buy
+260,771
New +$420K 0.15% 101

Other funds holding GROW

PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Invenomic Capital Management's GROW Position: Q2 2020 in Review

Invenomic Capital Management sold out of US Global Investors (GROW) in Q2 2020, closing a stake of 158,898 shares — an estimated $154K sold.

Invenomic Capital Management first reported a position in GROW in Q4 2019 and held it in 2 quarters. The position peaked at $376K in Q4 2019. 29 funds tracked by Wall St. Rank hold GROW as of Q2 2020.

  • Invenomic Capital Management reported no remaining US Global Investors position as of Q2 2020 after selling out during the quarter.
  • Invenomic Capital Management sold 158,898 US Global Investors shares in Q2 2020, an estimated $154K.
  • Invenomic Capital Management first reported a position in US Global Investors in Q4 2019 and held it in 2 quarters.
  • Invenomic Capital Management's US Global Investors position peaked at $376K in Q4 2019.
  • 29 funds tracked by Wall St. Rank held US Global Investors as of Q2 2020.

Based on Invenomic Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.